SC
NVO

Shay Capital’s Novo Nordisk NVO Stock Holding History

Shay Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,634
Closed -$433K – 387
2024
Q3 		$433K Sell
3,634
-13,278
-79% -$1.77M 0.06% 179
2024
Q2 		$2.41M Buy
16,912
+2,912
+21% +$386K 0.33% 56
2024
Q1 		$1.8M Buy
14,000
+9,000
+180% +$1.07M 0.28% 65
2023
Q4 		$517K Buy
+5,000
New +$494K 0.1% 129
2021
Q4 		– Sell
-7,490
Closed -$360K – 599
2021
Q3 		$360K Buy
+7,490
New +$362K 0.05% 304
2021
Q2 		– Sell
-6,000
Closed -$202K – 634
2021
Q1 		$202K Buy
+6,000
New +$214K 0.02% 370

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Shay Capital's NVO Position: Q4 2024 in Review

Shay Capital sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 3,634 shares — an estimated $433K sold.

Shay Capital first reported a position in NVO in Q1 2021 and held it in 6 quarters. The position peaked at $2.41M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Shay Capital reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Shay Capital sold 3,634 Novo Nordisk shares in Q4 2024, an estimated $433K.
  • Shay Capital first reported a position in Novo Nordisk in Q1 2021 and held it in 6 quarters.
  • Shay Capital's Novo Nordisk position peaked at $2.41M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Shay Capital's 13F filing for Q4 2024, filed 14 Feb 2025.